Thursday, September 17, 2015

Starting Treatment of Acute HCV Early: Is This the Best Option?

Starting Treatment of Acute HCV Early: Is This the Best Option?
David E. Kaplan, MD, MSC

Medicine and Research Services, Corporal Michael J. Crescenz VA Medical Center, Philadelphia PA; Division of Gastroenterology, Department of Medicine, University of Pennsylvania.

This article was published in the August/September 2015 issue of AGA Perspectives.

Acute hepatitis C continues to be encountered less frequently in routine GI clinical practice, except in relatively well-defined hot spots. The majority of acute hepatitis C cases are asymptomatic and usually escape early detection unless due to surveillance or luck, when abnormal liver enzyme tests are found. Symptomatic cases may manifest such protean symptoms that mild associated jaundice goes unnoticed by both patients and health-care providers alike.

No comments:

Post a Comment